Kevin J. Comcowich Net Worth

The estimated Net Worth of Kevin Comcowich is at least $148 mil dollars as of 17 September 2019. Mr Comcowich owns over 5,000 units of Arcadia Biosciences Inc stock worth over $57,200 and over the last 8 years he sold RKDA stock worth over $0. In addition, he makes $90,500 as Chairman & Interim CEO at Arcadia Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Comcowich RKDA stock SEC Form 4 insiders trading

Mr has made over 2 trades of the Arcadia Biosciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of RKDA stock worth $29,400 on 17 September 2019.

The largest trade he's ever made was buying 15,000 units of Arcadia Biosciences Inc stock on 10 September 2019 worth over $97,350. On average, Mr trades about 1,667 units every 1 days since 2016. As of 17 September 2019 he still owns at least 20,000 units of Arcadia Biosciences Inc stock.

You can see the complete history of Mr Comcowich stock trades at the bottom of the page.

Mr. Kevin J. Comcowich biography

Kevin J. Comcowich is the Chairman & Interim CEO at Arcadia Biosciences Inc.

What is the salary of Mr Comcowich?

As the Chairman & Interim CEO of Arcadia Biosciences Inc, the total compensation of Mr Comcowich at Arcadia Biosciences Inc is $90,500. There are 2 executives at Arcadia Biosciences Inc getting paid more, with Pamela Haley having the highest compensation of $240,000.

How old is Mr Comcowich?

Mr Comcowich is 52, he's been the Chairman & Interim CEO of Arcadia Biosciences Inc since . There are 5 older and 6 younger executives at Arcadia Biosciences Inc. The oldest executive at Arcadia Biosciences Inc is Donald Emlay, 73, who is the Vice President - Regulatory Affairs and Compliance.

What's Mr Comcowich's mailing address?

Kevin's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS, TX, 75225.

Insiders trading at Arcadia Biosciences Inc

Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp y Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.

What does Arcadia Biosciences Inc do?

arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.

Complete history of Mr Comcowich stock trades at Arcadia Biosciences Inc

Arcadia Biosciences Inc executives and stock owners

Arcadia Biosciences Inc executives and other stock owners filed with the SEC include:

• Pamela Haley,
  CFO & Corp. Sec.
• Laura Pitlik,
  Chief Marketing Officer
• Kevin J. Comcowich,
  Chairman & Interim CEO
• Amy Yoder,
  Director
• Gregory Waller,
  Director
• Lilian Shackleford Murray,
  Director
• Peter Gajdos,
  Director
• Albert Bolles,
  Director
• Jamie Bechtel,
  Director
• Sarah Reiter,
  Chief Commercial Officer
• Zhongjin Lu,
  Director - Product Development
• Kevin Hodges,
  Vice President - Commercial Operations
• Donald Emlay,
  Vice President - Regulatory Affairs and Compliance
• Tracy Baker,
  Vice President - Product Innovation
• Pamela Haley,
  Chief Financial Officer
• Matthew Plavan,
  Chief Executive Officer, Director
• Kevin Comcowich,
  Chairman of the Board
• Stanley E. Jacot Jr.,
  Pres, CEO & Director
• Stan Jacot,
  Pres & CEO
• Dr. Zhongjin Lu Ph.D.,
  Director of Product Devel.
• Brian Schaffer,
  Sr. VP of Sales
• Belinda Yao,
  VP of Operations
• George Frederick John Gosbee,
  Director
• Darby E Shupp,
  Director
• Rajiv Shah,
  Director
• Wendy S. Neal,
  VP, Chief Legal Officer
• James Richard Reis,
  Director
• Uday Garg,
  Director
• Matthew A. Ankrum,
  Director
• Steven F. Brandwein,
  VP Finance and Administration
• Roger Salameh,
  VP Business Development
• Mark Wong,
  Director
• Vic C. Knauf,
  Chief Scientific Officer
• Eric J. Rey,
  President and CEO
• Don Emlay,
  VP Regulatory and Compliance
• Agribusiness Co Investments...,
  
• Terri Csperling Peter V Mor...,
  
• Randall Shultz,
  Chief Technology Officer
• Chris Cuvelier,
  Chief Growth Officer
• Laura Pitlik,
  Chief Marketing Officer
• Stanley Jr Jacot,
  Chief Executive Officer
• Deborah D Carosella,
  
• Thomas J. Schaefer,
  Chief Executive Officer
• Mark Kawakami,
  Chief Financial Officer